Antiresorptive medication in oncology: the clinical and dental profile of patients in a reference center
Ferreira Vitor Hugo Candido, Kemp Aristilia Tahara, Vendruscolo Joana, Sassi Laurindo Moacir, Schussel Juliana Lucena,
소속 상세정보
( Ferreira Vitor Hugo Candido ) - Federal University of Parana Department of Stomatology
( Kemp Aristilia Tahara ) - Federal University of Parana Department of Stomatology
( Vendruscolo Joana ) - Erasto Gaertner Cancer Center Department of Oral and Maxillofacial Surgery
( Sassi Laurindo Moacir ) - Erasto Gaertner Cancer Center Department of Oral and Maxillofacial Surgery
( Schussel Juliana Lucena ) - Federal University of Parana Department of Stomatology
Abstract
Objectives: The aim of this study was to evaluate the profile of patients on antiresorptive therapies for cancer treatment and assess presence of oral lesions, oral hygiene status, and knowledge regarding medication-related osteonecrosis of the jaw (MRONJ).
Materials and Methods: This was an observational cross-sectional study that evaluated patients treated with antiresorptive medication at a single cancer hospital. Clinical data were collected and oral examination was performed to assess patient oral health.
Results: From July 2017 to December 2018, 90 patients were assessed; 64 were female and 26 were male, and the mean age was 61 years. The most common drug was an intravenous bisphosphonate, zoledronic acid. Among the 90 patients, 47 presented with some type of oral disease, isolated or associated.
Among these 47 patients, 9 patients (10%) developed osteonecrosis. Oral hygiene was evaluated, and most patients, with or without MRONJ, presented with regular to poor condition. Regarding patient knowledge of the risks of MRONJ and the risks associated with dental surgery, 60% stated that they were not aware of the risks.
Conclusion: Identifying the profile of patients and their needs facilitates not only the preventive process, but also the emergence of new therapeutic options. Our study shows that most patients are weakened both by metastatic disease and antineoplastic treatment as well as by issues associated with aging because most were over 60 years of age. Collectively, this information should be considered for management of preventive and therapeutic measures.
키워드
Osteonecrosis of the jaws; Medication-related osteonecrosis of the jaw; Antiresorptives
원문 및 링크아웃 정보
등재저널 정보